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Introduction {#sec001}
============

The cornea is composed of the outer stratified squamous epithelium, the intermediate stroma, and the inner endothelium.\[[@pone.0134157.ref001]\] The stroma consists of type I/V collagen fibers and proteoglycan decorin, lumican, keratocan, and osteoglycin/mimecan \[[@pone.0134157.ref002]\]. Type III collagen is also present in low proportions but it increases during wound healing and inflammation \[[@pone.0134157.ref003]\]. The keratocytes, located between the collagen lamellae in the stroma, are a population of quiescent, mesenchymal-derived cells \[[@pone.0134157.ref004]\]. Despite being sparsely arranged in the stroma, keratocytes form an interconnected cellular network through long dendritic processes \[[@pone.0134157.ref005]\].

Upon injury, the keratocytes may either undergo apoptosis or transdifferentiate into an activated fibroblastic repair phenotype. This fibroblastic phenotype seen in corneal wound healing resembles the phenotype that is seen under culture conditions *in vitro*. Standard culture conditions for corneal stromal cells (10% Fetal Calf Serum) alter the keratocytes from their *in situ* phenotype \[[@pone.0134157.ref006]\]. Of the total glycosaminoglycans (GAGs) synthesized by corneas in organ culture, 47% are keratan sulfates \[[@pone.0134157.ref007]\]. However, stromal cells derived from bovine, rabbit and human corneas, cultured under standard conditions, have been reported to produce moderate (15%), little (3%), or no keratan sulfates, respectively \[[@pone.0134157.ref006], [@pone.0134157.ref008]--[@pone.0134157.ref010]\]. Serum-cultured corneal stromal cells also express the fibronectin receptor a5b1 (which is not expressed by keratocytes *in situ*), they have a fibroblastic morphology, and their actin cytoskeleton resembles the one of corneal fibroblasts or even corneal myofibroblasts \[[@pone.0134157.ref011]--[@pone.0134157.ref013]\]. However, when primary cultures of corneal stromal cells are cultured in serum-free medium, they exhibit a dendritic morphology and extensive dendritic processes \[[@pone.0134157.ref014]\], and their appearance is similar to keratocytes *in situ* and distinctly different from the fibroblastic or myofibroblastic appearance of keratocytes grown in serum-containing medium \[[@pone.0134157.ref005], [@pone.0134157.ref014]\].

Stromal wound healing consists of three stages: repair, regeneration (proliferation and migration of keratocytes \[[@pone.0134157.ref015]\]), and remodeling \[[@pone.0134157.ref016]\], and has been shown to involve a complex interplay between cytokines, growth factors, and chemokines \[[@pone.0134157.ref017]\]. Based on a number of observations, it is likely that also other signal substances are at play such as neuropeptides \[[@pone.0134157.ref018]\] and other classical neuronal transmitters \[[@pone.0134157.ref019]--[@pone.0134157.ref021]\]. To further elucidate the role of such substances in corneal wound healing it is of importance to study their expression profiles in corneal stromal cells *in situ* and *in vitro*. Similarly, the presence of their receptors is also important to delineate, since the influence of neuropeptides/neurotransmitters on primary corneal cells may depend on not only non-neuronal but also neuronal signaling in the cornea.

The cornea is one of the most innervated tissues in the body, containing nerve fibers derived from the trigeminal ganglion. Previous studies have demonstrated that the corneal nerve fibers exert important trophic influences and contribute to the homeostatic maintenance of corneal epithelium \[[@pone.0134157.ref022]\]. However, the potential role of neuropeptides or neurotransmitters in corneal stromal wound healing remains poorly understood. Studies have confirmed the involvement of nerves, especially nerves secreting neuropeptides, in the processes of diabetic/skin wound healing, including inflammation, epithelialization, and fibrogenesis \[[@pone.0134157.ref023]--[@pone.0134157.ref027]\].

The neuropeptides substance P (SP) and neurokinin A (NKA) belong to the tachykinin family which have a variety of pharmacological actions both in the central nervous system and in the periphery \[[@pone.0134157.ref028]\]. SP and its preferred receptor, the neurokinin-1 receptor (NK-1R), have been found to be expressed by a wide range of not only neuronal but also non-neuronal human cells \[[@pone.0134157.ref018], [@pone.0134157.ref029]\] NKA signals through its high affinity receptor, the neurokinin-2 receptor (NK-2R). Acetylcholine (ACh) is regarded as a classical neurotransmitter, and it acts through either nicotinic ACh receptors (nAChRs) or muscarinic ACh receptors (mAChRs) \[[@pone.0134157.ref030]\]. Catecholamines (dopamine, adrenaline and noradrenaline) constitute a class of chemical neurotransmitters and hormones that occupy key positions in regulation of physiological processes. Adrenaline and noradrenaline act through α (α~1~ and α~2~) and β (β~1~ and β~2~) adrenoceptors (adrenergic receptors) in target cells whereas dopamine acts through its D~1~ (D~1~ and D~5~) and D~2~ (D~2~, D~3~ and D~4~) classes of receptors. Glutamate is a non-essential amino acid, which binds to the N-Methyl-D-aspartic acid receptor (NMDAR) and acts as a major neurotransmitter in the mammalian central nervous system. All these neuropeptides and neurotransmitters are known to exert effects on processes involved in wound healing.

Considering the importance of keratocytes in corneal stromal wound healing, it would be of interest to study the expression profiles of neuropeptides and neurotransmitters in human keratocytes. Therefore, as it has not been documented before and as a basis for further functional studies on the role of neuropeptides/neurotransmitters in corneal wound healing, the present work studied the endogenous intracellular and secreted levels of the tachykinins SP and NKA, and of ACh, catecholamines (adrenaline, noradrenaline and dopamine), and glutamate, as well as the expression profiles of their receptors, in human primary keratocytes *in vitro* and in keratocytes of human corneal tissue sections *in situ*.

Materials and Methods {#sec002}
=====================

Collection of human corneas {#sec003}
---------------------------

Healthy human corneas from deceased individuals who had chosen, when alive, to donate their corneas post-mortem for transplantation or research, through written consent and according to Swedish law, were kept in a tissue bank at the corneal donation center at the University Hospital of Umeå, Sweden (Hornhinnebanken Vävnadsinrättningen Laboratoriemedicin Norrlands universitetssjukhus, (<http://www.vavnad.se/cms/sites/vavnadsradet/home/hornhinnor/nationellt-arbete-1/umea.html>). If these healthy donated corneas were not used for transplantation after their collection, they were delivered to the laboratory for research purpose. The Regional Ethical Review Board in Umeå reviewed the study and determined it to be exempt from the requirement for approval (2010-373-31M). The study was performed according to the principles of the Declaration of Helsinki.

Isolation and primary culture of human keratocytes {#sec004}
--------------------------------------------------

Healthy human corneas were obtained from donated transplantation grafts, as described in the previous section. Samples were scraped using a sterile scalpel to remove any remaining epithelial or endothelial cells before being washed in sterile Hanks' Balanced Salt Solution (HBSS; Invitrogen, Carlsbad, CA, USA, \# 14170--138). Using a scalpel, the cornea was separated into two parts: the central part (round shaped, middle part of the cornea) and the peripheral part (ring shaped part consisting of limbus and surrounding tissue). Each part was then minced with a scalpel and digested in 2 mg/ml collagenase (Clostridopeptidase A, Sigma, St. Louis, MO, USA, \# C-1030) diluted in Dulbecco\'s Modified Eagle Medium: Nutrient Mixture F-12 (DMEM / F-12, Gibco, Carlsbad, CA, USA, \# 21331--046) for 30 minutes at 37°C. The samples were then transferred and cultured in DMEM / F-12 medium supplemented with 2% Fetal Bovine Serum (FBS; Gibco, \# 16000), 1% penicillin-streptomycin (Gibco, \# 15410) and 0.2% L-Glutamine (Gibco, \# 25030). The medium was replaced every second to third day until the cells reached confluence. Confluent cells were detached with 0.05% Trypsin-EDTA (Gibco, \# 25300) and split in a 1:3 ratio. Cells from passage 3 to 4 were used for experiments. For the experiments, cells were maintained in DMEM / F-12 supplemented with either 2% or 0% FBS (western blots, EIAs, ELISAs, colorimetric and fluorometric assays), or only 2% FBS (immunocytochemistry and real-time qPCR). Central part of the cornea and peripheral part (consisting of limbus + adjacent tissue) were analyzed and compared in this study.

Human corneal tissue sectioning {#sec005}
-------------------------------

Healthy human corneas were fixed in a solution of 4% formaldehyde diluted in 0.1 M Phosphate Buffered Saline (PBS) (pH 7.4) overnight. After three washes in a Tyrode's solution containing 10% sucrose the sample was mounted on a piece of cardboard with OCT embedding medium (Miles Laboratories, Elkhart, IN, USA) and frozen in liquid nitrogen-chilled propane. The corneas were then cut to 7 μm sections in a cryostat and sections were stored at -24°C until stained.

Immunocytochemistry {#sec006}
-------------------

10^4^ keratocytes per well were seeded in 8 well chamber slides (Corning, Corning, NY, USA \# 354118) overnight (in DMEM/F12 supplemented with 2% FBS) before being fixed in 2% paraformaldehyde (PFA) diluted in 0.1 M PBS (pH 7.4) for 10 minutes. Cells were permeabilized with 0.25% Triton X-100 in PBS for 10 minutes. Fixed cells were washed repeatedly in PBS and then blocked with 1:20 diluted normal serum ([Table 1](#pone.0134157.t001){ref-type="table"}) corresponding to the host species of the secondary antibody for 15 minutes. After carefully disposing of the serum, cells were incubated with the primary antibody ([Table 2](#pone.0134157.t002){ref-type="table"}) overnight at 4°C. Washing and blocking were repeated and secondary antibody ([Table 3](#pone.0134157.t003){ref-type="table"}) was added for 30 minutes at 37°C. Cells were then washed before being mounted in Vectashield mounting medium for fluorescence (Vector Laboratories, Burlingame, CA, USA \# H-1500). A control well was also prepared for each secondary antibody by replacing the primary antibody with PBS. A Zeiss Axioskop 2 plus microscope equipped with epifluorescence and an Olympus DP70 digital camera were used for analysis.

10.1371/journal.pone.0134157.t001

###### Normal sera used for immunocytochemistry and immunohistochemistry.

![](pone.0134157.t001){#pone.0134157.t001g}

  Serum    Code          Source                             Dilution
  -------- ------------- ---------------------------------- ----------
  Donkey   017-000-121   Jackson I.R. West Grove, PA, USA   1:20
  Rabbit   X0902         Dako, Glostrup, Denmark            1:20
  Swine    014-000-121   Jackson I.R. West Grove, PA, USA   1:20

10.1371/journal.pone.0134157.t002

###### Primary antibodies used for immunocytochemistry and immunohistochemistry.

![](pone.0134157.t002){#pone.0134157.t002g}

  Antigen                          Code         Source                                         Type     Dilution
  -------------------------------- ------------ ---------------------------------------------- -------- ----------
  Keratocan                        sc-66941     Santa Cruz Biotechnology, Dallas, TX, USA      rabbit   1:50
  α-SMA                            ab5649       Abcam, Cambridge, UK                           rabbit   1:50
  Lumican                          sc-166871    Santa Cruz Biotechnology, Dallas, TX, USA      mouse    1:50
  CD31                             M0823        Dako, Glostrup, Denmark                        mouse    1:50
  SP                               8450--0004   Serotec, Oxford, UK                            rabbit   1:50
  NK-2R                            NBP1-00948   Novus Biologicals, Cambridge, UK               rabbit   1:100
  NK-1R                            sc-5220      Santa Cruz Biotechnology, Dallas, TX, USA      goat     1:100
  mAChR M1                         sc-9106      Santa Cruz Biotechnology, Dallas, TX, USA      rabbit   1:100
  mAChR M2                         sc-9107      Santa Cruz Biotechnology, Dallas, TX, USA      rabbit   1:100
  mAChR M3                         sc-9108      Santa Cruz Biotechnology, Dallas, TX, USA      rabbit   1:100
  mAChR M4                         sc-9109      Santa Cruz Biotechnology, Dallas, TX, USA      rabbit   1:100
  mAChR M5                         sc-9110      Santa Cruz Biotechnology, Dallas, TX, USA      rabbit   1:100
  TH                               sc-14007     Santa Cruz Biotechnology, Dallas, TX, USA      rabbit   1:50
  Glutamate                        G6642        Sigma, St. Louis, MO, USA                      rabbit   1:100
  NKA                              H-046-15     Phoenix Pharmaceuticals, Burlingame, CA, USA   rabbit   1:100
  ChAT                             AB143        Millipore, Billerica, MA, USA                  rabbit   1:100
  NMDAR1                           ab134308     Abcam, Cambridge, UK                           mouse    1:250
  α1 adrenergic receptor (ADRA1)   ab3462       Abcam, Cambridge, UK                           rabbit   1:500
  β2 adrenergic receptor (ADRB2)   ab61778      Abcam, Cambridge, UK                           rabbit   1:250
  Dopamine D2 Receptor (DRD2)      ab32349      Abcam, Cambridge, UK                           goat     1:250
  CD45                             ab10558      Abcam, Cambridge, UK                           rabbit   1:500

10.1371/journal.pone.0134157.t003

###### Secondary antibodies used for immunocytochemistry and immunohistochemistry.

![](pone.0134157.t003){#pone.0134157.t003g}

  Secondary antibody                   Code      Source                          Dilution
  ------------------------------------ --------- ------------------------------- ----------
  Alexa Fluor 488, donkey anti-goat    A-11055   Invitrogen, Carlsbad, CA, USA   1:300
  TRITC-conjugated rabbit anti-mouse   R0270     Dako, Glostrup, Denmark         1:20
  TRITC-conjugated swine anti-rabbit   R0156     Dako, Glostrup, Denmark         1:40

Immunohistochemistry {#sec007}
--------------------

Tissue sections were fixed in 2% PFA and permeabilized with 1% Triton X-100 for 20 minutes. Slides were then washed 3 times in PBS and blocked with 1:20 diluted normal serum ([Table 1](#pone.0134157.t001){ref-type="table"}) for 15 minutes. After carefully disposing of the serum, cells were incubated with the primary antibody ([Table 2](#pone.0134157.t002){ref-type="table"}) overnight at 4°C. The same antibodies were used as for immunocytochemistry. Washing and blocking were repeated and secondary antibody ([Table 3](#pone.0134157.t003){ref-type="table"}) was added for 30 minutes at 37°C. Sections were then washed before being mounted in Vectashield mounting medium for fluorescence (Vector Laboratories, \# H-1500). A control slide was also prepared for each secondary antibody by replacing the primary antibody with PBS. A Zeiss Axioskop 2 plus microscope equipped with epifluorescence and an Olympus DP70 digital camera were used for analysis.

Measurements of neuropeptides and neurotransmitters {#sec008}
---------------------------------------------------

250,000 keratocytes were seeded into 6 wells plates in triplicates in DMEM / F-12 medium supplemented with either 2% or 0% FBS. After 24 h of culture, supernatants were collected and cells were lysed in RIPA lysis buffer. Neuropeptides and neurotransmitters were measured using following kits according to manufacturer's specifications: Substance P EIA kit (Phoenix Pharmaceuticals, Burlingame, CA, USA, \# EK-061-05), Neurokinin A EIA kit (RayBiotech, Norcross, GA, USA, \# EIA-NEA1), Amplex Acetylcholine/Acetlycholinesterase Assay Kit (Life Technologies, Carlsbad, CA, USA), Glutamate Assay kit (Abcam, \# 83389), and Adrenaline/Noradrenaline/Dopamine 3-CAT ELISA (Labor Diagnostika Nord, Nordhorn, Germany, \# BA E-5600).

Western blot {#sec009}
------------

250,000 keratocytes were seeded into 6 well plates in DMEM / F-12 medium supplemented with either 2% or 0% FBS. After 24h of culture, cells were washed with PBS and frozen at -80°C overnight. Cells were lysed in RIPA lysis buffer supplemented with 0.5% Proteinase inhibitor cocktail (Sigma, \# P1860) and diluted in Laemmli Sample buffer supplemented with 2-mercaptoethanol. The cell lysates were separated by sodium dodecyl sulfate / polyacrylamide gel electrophoresis and transferred to PVDF membranes. Blots were incubated with primary antibodies listed in [Table 4](#pone.0134157.t004){ref-type="table"}. The antigens were detected with horseradish peroxidase-conjugated secondary antibodies listed in [Table 5](#pone.0134157.t005){ref-type="table"}. The images were taken by Odyssey Fc imaging system (LI-COR, Lincoln, NE, USA). Densitometry was performed using Image J analysis software (NIH).

10.1371/journal.pone.0134157.t004

###### Primary antibodies used in western blot analysis.

![](pone.0134157.t004){#pone.0134157.t004g}

  Antigen                       Code         Source                                      Type     Dilution
  ----------------------------- ------------ ------------------------------------------- -------- ----------
  Keratocan                     sc-66941     Santa Cruz Biotechnology, Dallas, TX, USA   rabbit   1:200
  Lumican                       sc-166871    Santa Cruz Biotechnology, Dallas, TX, USA   mouse    1:200
  CD34                          sc-9095      Santa Cruz Biotechnology, Dallas, TX, USA   rabbit   1:200
  ALDH                          ab52492      Abcam, Cambridge, UK                        rabbit   1:500
  Procollagen I (Pro-COL1A1)    sc-8782      Santa Cruz Biotechnology, Dallas, TX, USA   goat     1:200
  Collagen I (COL1A1)           ab34710      Abcam, Cambridge, UK                        rabbit   1:500
  NK-1R                         MAB6687      R&D Systems, Abingdon, UK                   mouse    1:100
  NK-2R                         NBP1-00948   Novus Biologicals, Cambridge, UK            rabbit   1:100
  TH                            sc-14007     Santa Cruz Biotechnology, Dallas, TX, USA   rabbit   1:200
  Dopamine D2 Receptor (DRD2)   ab32349      Abcam, Cambridge, UK                        goat     1:500
  mAChR M1                      sc-9106      Santa Cruz Biotechnology, Dallas, TX, USA   rabbit   1:200
  mAChR M3                      sc-9108      Santa Cruz Biotechnology, Dallas, TX, USA   rabbit   1:200
  mAChR M4                      sc-9109      Santa Cruz Biotechnology, Dallas, TX, USA   rabbit   1:200
  mAChR M5                      sc-9110      Santa Cruz Biotechnology, Dallas, TX, USA   rabbit   1:200
  NMDAR1                        ab134308     Abcam, Cambridge, UK                        mouse    1:500

10.1371/journal.pone.0134157.t005

###### HRP-linked secondary antibodies.

![](pone.0134157.t005){#pone.0134157.t005g}

  Secondary antibody           Code      Source                                      Dilution
  ---------------------------- --------- ------------------------------------------- ----------
  Anti-rabbit IgG HRP-linked   7074      Cell Signaling, Danvers, MA, USA            1:2000
  Anti-mouse IgG HRP-linked    7076      Cell Signaling, Danvers, MA, USA            1:2000
  Anti-goat IgG HRP-linked     sc-2020   Santa Cruz Biotechnology, Dallas, TX, USA   1:2000

Real-time qPCR {#sec010}
--------------

250,000 keratocytes were seeded into 6 wells plates in triplicates in DMEM/F12 supplemented with 2% FBS. After 24 h RNA was extracted using RNeasy Mini Kit (Qiagen, Venlo, The Netherlands, \#74104). 900 ng of RNA was reverse transcribed into cDNA using High Capacity cDNA Reverse Transcription Kit (Life Technologies, Carlsbad, CA, USA, \# 4368814). To determine the gene expression TaqMan Gene Expression Assays (Applied Biosystems, Carlsbad, USA) were used. cDNA obtained from 40 ng of RNA was run in duplicates by ViiA 7 Real-Time PCR system (Applied Biosystems), and analyzed by ViiA 7 Software (Applied Biosystems). Expression of genes of interest was normalized to the expression of 18S housekeeping gene. Analyzed genes are listed in [Table 6](#pone.0134157.t006){ref-type="table"}.

10.1371/journal.pone.0134157.t006

###### Gene expression assays.

![](pone.0134157.t006){#pone.0134157.t006g}

  Gene     ID
  -------- ---------------
  ADRA1B   Hs00171263_m1
  ADRB2    Hs00240532_s1
  CHRM1    Hs00265195_s1
  CHRM2    Hs00265208_s1
  CHRM3    Hs00265216_s1
  CHRM4    Hs00265219_s1
  CHRM5    Hs00255278_s1
  DDC      Hs01105048_m1
  DRD2     Hs00241436_m1
  GLS      Hs00248163_m1
  GOT      Hs00157798_m1
  TAC1     Hs00243225_m1
  TACR1    Hs00185530_m1
  TACR2    Hs00169052_m1

Statistical analysis {#sec011}
--------------------

Data represent mean ± SD of three replicates. Independent samples *t*-test or one-way ANOVA with Bonferroni post hoc test were applied to determine if there was a statistically significant difference between samples. GraphPad Prism 5 software was used for data analysis. Significance was predetermined at p\<0.05. Experiments were performed successfully at least 3 times. Primary cultures of keratocytes obtained from different cornea donors were assessed individually.

Results {#sec012}
=======

Characterization of isolated keratocytes *in vitro* {#sec013}
---------------------------------------------------

Immunohistochemistry of the human corneal tissue showed that the cornea expresses keratocan, a cornea-specific keratan sulfate proteoglycan, \[[@pone.0134157.ref031]\], and lumican which is a keratan sulfate proteoglycan produced by keratocytes \[[@pone.0134157.ref031]\]([Fig 1A](#pone.0134157.g001){ref-type="fig"}). In order to determine the characteristics and phenotype of cultured corneal cells, and how the culturing conditions affect the cultured cells phenotype, four keratocyte markers were used: keratocan, lumican, CD34 (hematopoietic stem cell marker and an adhesion molecule \[[@pone.0134157.ref032]\] and aldehyde dehydrogenase (ALDH; corneal crystalline which contributes to maintaining corneal transparency \[[@pone.0134157.ref033]\]). Western blot and densitometry analyses were performed. Two culture conditions were tested. Central and peripheral keratocytes were cultured in either DMEM/F12 medium supplemented with 2% FBS or 0% FBS. Central keratocytes grown in these two conditions, as well as peripheral keratocytes grown in these two conditions, were compared. Moreover, comparison was made between central and peripheral keratocytes. Keratocan was expressed abundantly in cultured cells. Its expression was significantly higher in peripheral keratocytes cultured in 2% FBS than in central keratocytes grown in 2% FBS. Central keratocytes grown in 0% FBS expressed more keratocan than central keratocytes grown in 2% FBS and peripheral keratocytes grown in 0% FBS. However, peripheral keratocytes grown in 0% FBS had significantly lower expression of keratocan when compared to peripheral keratocytes grown in 2% FBS. Lumican was also expressed abundantly in cultured cells. Peripheral keratocytes expressed significantly more lumican than central keratocytes. CD34 was also expressed in cultured keratocytes. Its expression was significantly higher in peripheral keratocytes grown in 2% FBS than in central keratocytes grown in 2% FBS and peripheral keratocytes grown in 0% FBS. CD34 expression was also significantly higher in central keratocytes grown in 2% FBS in comparison to central keratocytes grown in 0% FBS. ALDH was expressed in cultured keratocytes but at very low levels. Peripheral keratocytes grown in 2% FBS expressed significantly more ALDH than central keratocytes grown in 2% FBS and peripheral keratocytes grown in 0% FBS ([Fig 1B](#pone.0134157.g001){ref-type="fig"}). Moreover, expression of procollagen I and collagen I was assessed. Procollagen I was significantly higher in central keratocytes grown in 2% FBS than in peripheral keratocytes grown in same conditions. Collagen I expression was significantly higher in central keratocytes grown in 2% FBS than in central keratocytes grown in 0% FBS and peripheral keratocytes grown in 2% FBS. Also, collagen I expression was significantly lower in central keratocytes grown in 0% FBS than in peripheral keratocytes grown in same conditions ([Fig 1C](#pone.0134157.g001){ref-type="fig"}). Additionally, cultured keratocytes did not express CD45, a common marker for bone marrow-derived cells, CD31, a marker of endothelial cells and expressed only small amount of α-SMA, a marker of myofibroblasts (data not shown).

![Characterization of isolated keratocytes and keratocytes in cornea tissue sections.\
**(A)** Human corneal sections were characterized by immunohistochemistry. Sections were double stained for the nuclei (DAPI; blue) together with keratocan (top panel) or lumican (bottom panel) (both TRITC; red). Both keratocan and lumican were expressed by keratocytes in corneal sections. **(B-C)** 250,000 cells were grown for 24h in 6 well plates in DMEM/F12 supplemented with either 2% or 0% FBS and subjected to western blot analysis. **(B)** Four keratocyte markers were analyzed: keratocan (50 kDa), lumican (46 kDa), CD34 (90--120 kDa) and ALDH (55 kDa). Keratocan was expressed in cultured cells. Its expression was significantly higher in peripheral keratocytes cultured in 2% FBS than in central keratocytes grown in 2% FBS (\*\*\*p\<0.001). Central keratocytes grown in 0% FBS expressed more keratocan than central keratocytes grown in 2% FBS (\*\*\*p\<0.001) and peripheral keratocytes grown in 0% FBS (\*\*\*p\<0.001). However, peripheral keratocytes grown in 0% FBS had significantly lower expression of keratocan than peripheral keratocytes grown in 2% FBS (\*\*\*p\<0.001), Lumican was expressed in cultured cells. Peripheral keratocytes expressed significantly more lumican than central keratocytes (\*p\<0.05 for 2% FBS, \*p\<0.05 for 0% FBS). CD34 was expressed in cultured keratocytes. Its expression was significantly higher in peripheral keratocytes grown in 2% FBS than in central keratocytes grown in 2% FBS (\*p\<0.05) and peripheral keratocytes grown in 0% FBS (\*\*\*p\<0.001). CD34 expression was also significantly higher in central keratocytes grown in 2% FBS than in central keratocytes grown in 0% FBS (\*p\<0.05). ALDH was expressed in cultured keratocytes but at low levels. Peripheral keratocytes grown in 2% FBS expressed significantly more ALDH than central keratocytes grown in 2% FBS (\*\*\*p\<0.001) and peripheral keratocytes grown in 0% FBS (\*\*\*p\<0.001). (C) Expression of procollagen I (140--210 kDa) and collagen I (139 kDa) was analyzed in cultured keratocytes. Procollagen I was expressed by cultured keratocytes. Its expression was significantly higher in central keratocytes grown in 2% FBS than in peripheral keratocytes grown in same conditions (\*p\<0.05). Collagen I expression was significantly higher in central keratocytes grown in 2% FBS than in central keratocytes grown in 0% FBS (\*\*\*p\<0.001) and peripheral keratocytes grown in 2% FBS (\*\*\*p\<0.001). Also, collagen I expression was significantly lower in central keratocytes grown in 0% FBS than in peripheral keratocytes grown in same conditions (\*\*\*p\<0.001). β-actin (42 kDa) served as a loading control. Values are means± SD.](pone.0134157.g001){#pone.0134157.g001}

Human keratocytes express genes coding for neuropeptides, and for catecholamine and glutamate synthesizing enzymes {#sec014}
------------------------------------------------------------------------------------------------------------------

In order to study if cultured keratocytes express genes coding for neuropeptides or for enzymes taking part in the synthesis of catecholamines and glutamate, qPCR was performed ([S1 Fig](#pone.0134157.s001){ref-type="supplementary-material"}). The gene coding for substance P and neurokinin A (TAC1) was present both in central and peripheral keratocytes. The DDC gene, which codes for DOPA decarboxylase, an enzyme involved in catecholamine synthesis, was also present in both central and peripheral keratocytes. The glutaminase gene (GLS), which codes for glutaminase that generates glutamate from glutamine, and the GOT gene coding for aspartate aminotransferase, which plays a role in amino acid metabolism, were both present in central and peripheral keratocytes.

Human keratocytes express genes coding for receptors of neuropeptides, catecholamines, and acetylcholine {#sec015}
--------------------------------------------------------------------------------------------------------

Genes coding for receptors of neuropeptides, catecholamines, and ACh were analyzed by qPCR ([S1 Fig](#pone.0134157.s001){ref-type="supplementary-material"}). TACR1 gene, coding for the preferred receptor of SP, the NK-1R, and TACR2 gene, which is the gene for the preferred receptor of neurokinin A (NK-2R), were present in both central and peripheral keratocytes. mRNA for adrenaline and noradrenaline adrenoreceptors α~1~ (ADRA1B) and β~2~ (ADRB2) were present in central keratocytes and peripheral keratocytes. DRD2 gene, coding for another catecholamine receptor, the dopamine receptor D~2~, was also present in both central and peripheral keratocytes. Genes for muscarinic acetylcholine receptors--CHRM1 (for mAChR M~1~), CHRM2 (for mAChR M~2~), CHRM3 (for mAChR M~3~), CHRM4 (for mAChR M~4~), and CHRM5 (for mAChR M~5~) were found in central and peripheral keratocytes.

Human keratocytes produce substance P and neurokinin A, and express their preferred receptors {#sec016}
---------------------------------------------------------------------------------------------

Presence and differences in amounts of the neuropeptides SP and NKA in cultures of human keratocytes was measured by EIA. Two culture conditions were tested. Central and peripheral keratocytes were cultured in either DMEM/F12 medium supplemented with 2% FBS or 0% FBS. Central keratocytes grown in these two conditions, as well as peripheral keratocytes grown in these two conditions, were compared. Moreover, comparison was made between central and peripheral keratocytes. SP levels were significantly higher in supernatants of central keratocytes grown in medium supplemented with 2% FBS than in peripheral keratocytes grown in medium supplemented with 2% FBS. SP secretion was significantly higher in central keratocytes grown in 2% FBS than central keratocytes grown in 0% FBS. However, there were no significant differences in SP levels in lysates of keratocytes ([Fig 2A](#pone.0134157.g002){ref-type="fig"}). NKA secretion was also significantly higher in central keratocytes grown in 2% FBS when compared to central keratocytes grown in 0% FBS ([Fig 2B](#pone.0134157.g002){ref-type="fig"}). Expression of SP and of its preferred receptor, NK-1R, was furthermore analyzed by immunohistochemistry and immunocytochemistry. Both the keratocytes in tissue sections and the cultured keratocytes expressed SP and a full-length version of NK-1R, composed of 407 amino acid residues ([Fig 2C](#pone.0134157.g002){ref-type="fig"}). Expression of NKA and of its receptor, NK-2R, was also analyzed by immunohistochemistry and immunocytochemistry. Both the keratocytes in tissue sections and the cultured keratocytes expressed NKA and NK-2R ([Fig 2D](#pone.0134157.g002){ref-type="fig"}). To quantify differences in expression of NK-1R and NK-2R between the different culturing conditions and central and peripheral keratocytes, western blot and densitometry analyses were performed. Expression of NK-1R was significantly higher in central keratocytes grown in 2% FBS when compared to peripheral keratocytes grown in same conditions. Expression of NK-1R was also significantly higher in central keratocytes grown in 2% FBS than in central keratocytes grown in 0% FBS ([Fig 2E](#pone.0134157.g002){ref-type="fig"}). On the other hand, expression of NK-2R was significantly higher in central keratocytes grown in 0% FBS than in peripheral keratocytes grown in same conditions. NK-2R expression was significantly higher in central keratocytes grown in 0% FBS than in central keratocytes grown in 2% ([Fig 2F](#pone.0134157.g002){ref-type="fig"}).

![Substance P and neurokinin A expression in keratocytes of cornea tissue sections and in cultured primary keratocytes.\
**(A-B)** Substance P **(A)** and neurokinin A **(B)** EIA of central and peripheral cultured keratocytes. 250,000 cells were grown for 24h in 6 well plates in DMEM/F12 supplemented with either 2% or 0% FBS. Supernatant was collected, cells were lysed and subjected to EIA. **(A)** SP levels were significantly higher in supernatants of central keratocytes grown in medium supplemented with 2% FBS than in peripheral keratocytes grown in medium supplemented with 2% FBS (\*\*\*p\<0.001). SP secretion was significantly higher in central keratocytes grown in 2% FBS than central keratocytes grown in 0% FBS (\*\*\*p\<0.001). There were no significant differences in SP levels in lysates of keratocytes. **(B)** NKA secretion was significantly higher in central keratocytes grown in 2% FBS than in central keratocytes grown in 0% FBS (\*p\<0.05). **(C)** Keratocytes in sections (left panel), as well as cultured central (middle panel) and peripheral (right panel) keratocytes, were labeled with an antibody targeting SP (top row; TRITC; red) and double stained with DAPI to visualize the nuclei (blue). Sections and cultured cells were also labeled with an antibody targeting full-length NK-1R (bottom row; Alexa Fluor 488; green) and double stained with DAPI. Both the keratocytes in tissue sections and the cultured keratocytes expressed SP and a full-length version of NK-1R. **(D)** Keratocytes in sections (left panel), as well as cultured central (middle panel) and peripheral (right panel) keratocytes, were labeled with an antibody targeting NKA (top row; TRITC; red) and NK-2R (bottom row; TRITC; red) and double stained with DAPI. Both the keratocytes in tissue sections and the cultured keratocytes expressed NKA and NK-2R. **(E-F)** 250,000 central keratocytes or peripheral keratocytes grown in DMEM/F12 supplemented with either 2% or 0% FBS were subjected to western blot analysis for NK-1R (46 kDa) and NK-2R (48 kDa) expression. **(E)** Expression of NK-1R was significantly higher in central keratocytes grown in 2% FBS than in peripheral keratocytes grown in same conditions (\*\*\*p\<0.001). Expression of NK-1R was also significantly higher in central keratocytes grown in 2% FBS than in central keratocytes grown in 0% FBS (\*\*\*p\<0.001). **(F)** Expression of NK-2R was significantly higher in central keratocytes grown in 0% FBS than in peripheral keratocytes grown in same conditions (\*\*\*p\<0.001). NK-2R expression was significantly higher in central keratocytes grown in 0% FBS than in central keratocytes grown in 2% (\*\*\*p\<0.001). n.s. (non significant; p\>0.05). β-actin (42 kDa) served as a loading control. Values are means ± SD.](pone.0134157.g002){#pone.0134157.g002}

Human keratocytes produce catecholamines and express their receptors {#sec017}
--------------------------------------------------------------------

Presence and differences in amounts of catecholamines (adrenaline, noradrenaline, and dopamine) was measured by ELISA. Again, two culture conditions were tested. Central and peripheral keratocytes were cultured in either DMEM/F12 medium supplemented with 2% FBS or 0% FBS. Central keratocytes grown in these two conditions, as well as peripheral keratocytes grown in these two conditions, were compared. Moreover, comparison was made between central and peripheral keratocytes. Adrenaline was present in both culture supernatant and lysates of cultured central and peripheral keratocytes, with significantly higher levels in supernatants collected from peripheral cells. However, in cell lysates levels of intracellular adrenaline were significantly higher in central keratocytes grown in 2% FBS in comparison with peripheral keratocytes grown in 2% FBS. Central keratocytes grown in 2% FBS showed higher levels of adrenaline than central keratocytes grown in 0% FBS. Moreover, peripheral keratocytes grown in 0% FBS had higher levels of adrenaline than central keratocytes grown in same conditions ([Fig 3A](#pone.0134157.g003){ref-type="fig"}). Noradrenaline was secreted from both central and peripheral keratocytes, and was also present in cell lysates. Peripheral keratocytes grown in 0% FBS secreted significantly higher amounts of noradrenaline than central keratocytes grown in same conditions. Intracellular levels of noradrenaline were significantly higher in peripheral keratocytes grown in 2% FBS than in peripheral keratocytes grown in 0% FBS ([Fig 3B](#pone.0134157.g003){ref-type="fig"}). Dopamine was secreted from both central and peripheral keratocytes and its levels were significantly higher in lysates of central keratocytes than peripheral keratocytes. Expression of tyrosine hydroxylase (TH), the enzyme responsible for catalyzing the conversion of the amino acid L-tyrosine to L-DOPA (precursor of adrenaline, noradrenaline, and dopamine), was analyzed by immunohistochemistry and immunocytochemistry. The cultured keratocytes expressed TH whereas keratocytes in tissue sections did not. In order to quantify and compare TH expression under different culturing conditions and two types of keratocytes (central vs. peripheral), western blot and densitometry analyses were performed. Both central and peripheral keratocytes grown in 2% FBS expressed more TH than cells grown in 0%. Moreover, central keratocytes grown in 2% FBS expressed more TH than peripheral keratocytes grown in same conditions ([Fig 3D](#pone.0134157.g003){ref-type="fig"}). Adrenaline and noradrenaline adrenoreceptors α~1~ and β~2~ (ADRA1, ADRB2, respectively) were not expressed in corneal tissue sections ([Fig 3E](#pone.0134157.g003){ref-type="fig"}) Expression of these receptors in cultured keratocytes was inconclusive. However, dopamine D2 receptor (DRD2) was expressed in both keratocytes in tissue sections and in cultured keratocytes. Western blot and densitometry analyses showed that central keratocytes grown in 2% FBS had significantly higher expression of DRD2 than both central keratocytes grown in 0% FBS and peripheral cells grown in 2% FBS ([Fig 3F](#pone.0134157.g003){ref-type="fig"}). The expression of TH in cultured cells but not in cells of tissue sections might be a result of culturing conditions.

![Catecholamines and their receptors expression in keratocytes of cornea tissue sections and cultured primary keratocytes.\
(**A-C**) Adrenaline, noradrenaline and dopamine ELISAs of lysates and supernatants of central and peripheral cultured keratocytes. 250,000 cells were grown for 24h in 6 well plates in DMEM/F12 supplemented with either 2% or 0% FBS. Supernatant was collected, cells were lysed and subjected to ELISA. **(A)** Levels of secreted adrenaline were significantly higher in peripheral keratocytes grown in both 2% and 0% FBS than in central keratocytes grown in same conditions (\*p\<0.05 for 2% FBS and \*\*p\<0.01 for 0% FBS). Levels of intracellular adrenaline were significantly higher in central keratocytes grown in 2% FBS than in peripheral keratocytes grown in 2% FBS (\*p\<0.05). Central keratocytes grown in 2% FBS had higher levels of adrenaline than central keratocytes grown in 0% FBS (\*\*\*p\<0.001). Moreover, peripheral keratocytes grown in 0% FBS had higher levels of adrenaline than central keratocytes grown in same the same condition (\*\*\*p\<0.001). **(B)** Noradrenaline was secreted from both central and peripheral keratocytes and was also present in cell lysates. Secreted noradrenaline levels were significantly higher in peripheral keratocytes grown in 0% FBS than in central keratocytes grown in same conditions (\*p\<0.05). Intracellular levels of noradrenaline were significantly higher in peripheral keratocytes grown in 2% FBS than peripheral keratocytes grown in 0% FBS. **(C)** Dopamine was secreted from both central and peripheral keratocytes. Dopamine levels were significantly higher in lysates of central keratocytes than peripheral keratocytes (\*\*\*p\<0.001 for both 2% FBS and 0% FBS). **(D)** Keratocytes in sections (left panel), as well as cultured central (middle panel) and peripheral (right panel) keratocytes, were labeled with an antibody targeting tyrosine hydroxylase (TH; TRITC; red) and double stained with DAPI to visualize the nuclei (blue). Cultured keratocytes expressed TH whereas keratocytes in tissue sections did not. 250,000 central or peripheral keratocytes grown in either 2% FBS or 0% FBS were lysed and expression of TH (60 kDa) was analyzed by western blot. Both central and peripheral keratocytes grown in 2% FBS expressed more TH than cells grown in 0% FBS (\*\*\*p\<0.001 for central keratocytes, \*\*p\<0.01 for peripheral keratocytes). Moreover, central keratocytes grown in 2% FBS expressed more TH than peripheral keratocytes grown in same conditions (\*\*p\<0.01). β-actin (42 kDa) served as a loading control. **(E)** Sections were labeled with adrenergic receptor antibodies, ADRA1 (left; TRITC, red) and ADRB2 (right; TRITC, red) and double stained with DAPI (blue). Keratocytes in tissue sections did not express either of the adrenergic receptors. **(F)** Keratocytes in sections (left panel), as well as cultured central (middle panel) and peripheral (right panel) keratocytes, were labeled with an antibody targeting dopamine receptor DRD2 (Alexa Fluor 488; green) and double stained with DAPI to visualize the nuclei (blue). DRD2 was expressed in both keratocytes in tissue sections and in cultured keratocytes. 250,000 central or peripheral keratocytes grown in either 2% FBS or 0% FBS were lysed and expression of DRD2 (51 kDa) was analyzed by western blot. Central keratocytes grown in 2% FBS had significantly higher expression of DRD2 than both central keratocytes grown in 0% FBS (\*p\<0.05) and peripheral cells grown in 2% FBS (\*p\<0.05). β-actin (42 kDa) served as a loading control. Values are means ± SD.](pone.0134157.g003){#pone.0134157.g003}

Human keratocytes produce acetylcholine and express muscarinic acetylcholine receptors {#sec018}
--------------------------------------------------------------------------------------

Presence and differences in amount of ACh was measured by fluorometric assay. Two culture conditions were tested. Central and peripheral keratocytes were cultured in either DMEM/F12 medium supplemented with 2% FBS or 0% FBS. Central keratocytes grown in these two conditions, as well as peripheral keratocytes grown in these two conditions, were compared. Moreover, comparison was made between central and peripheral keratocytes. Both central and peripheral keratocytes secreted ACh, and ACh was also present in both central and peripheral keratocyte lysates ([Fig 4A](#pone.0134157.g004){ref-type="fig"}). Expression of choline acetyltransferase (ChAT)--an enzyme that is crucial for ACh synthesis--was analyzed by immunohistochemistry and immunocytochemistry. Both the keratocytes in tissue sections and the cultured keratocytes expressed ChAT ([Fig 4B](#pone.0134157.g004){ref-type="fig"}). Muscarinic acetylcholine receptors: mAChR M~1~, mAChR M~2~, mAChR M~3~, mAChR M~4~, and mAChR M~5~ expression was analyzed by immunohistochemistry and immunocytochemistry ([Fig 4C](#pone.0134157.g004){ref-type="fig"}). mAChR M~1~ was present in cultured cells but not in tissue sections, mAChR M~2~ was absent in both cultured cells and tissue sections. The remaining receptor subtypes (mAChR M~3~, mAChR M~4~, and mAChR M~5~) were expressed in both tissue sections and cultured cells. Presence of mAChR M~1~ in culture but its absence in tissue sections might, again, be a result of culturing conditions and/or stressed cells. In order to quantify and compare expression levels of muscarinic acetylcholine receptors under different culturing conditions and two types of keratocytes, western blot and densitometry analyses were performed. mAChR M~1~ expression was significantly higher in central keratocytes grown in 0% FBS than in central keratocytes grown in 2% FBS, and also significantly higher in peripheral keratocytes grown in 2% FBS than in central keratocytes grown in same conditions, and finally significantly higher in central keratocytes grown in 0% FBS than in peripheral keratocytes grown in same condition. mAChR M~3~ expression was significantly higher in central keratocytes grown in 2% FBS than in both central keratocytes grown in 0% FBS and peripheral keratocytes grown in 2% FBS. Central keratocytes grown in 0% FBS expressed significantly more mAChR M~3~ than peripheral keratocytes grown in same the condition, and peripheral keratocytes grown in 2% FBS expressed more mAChR M~3~ than peripheral cells grown in 0% FBS. Expression of mAChR M~4~ was significantly higher in central keratocytes grown in 2% FBS than in peripheral keratocytes grown in same the condition. Expression of mAChR~5~ was significantly higher in peripheral keratocytes grown in 2% FBS than in both central keratocytes grown in the same condition and in peripheral keratocytes grown in 0% FBS. mAChR~5~ expression was also significantly higher in central keratocytes grown in 0% FBS than in peripheral keratocytes grown in same the condition ([Fig 4D](#pone.0134157.g004){ref-type="fig"}).

![Acetylcholine and its receptors expression in keratocytes.\
**(A)** 250,000 cells were grown for 24h in 6 well plates in DMEM/F12 supplemented with either 2% or 0% FBS. Supernatant was collected and subjected to acetylcholine (ACh) assay and cells were lysed. Both central and peripheral keratocytes secreted ACh (*n*.*s*.; p≥0.05). ACh was also present in both central and peripheral keratocyte lysates (*n*.*s*.; p≥0.05). **(B)** Keratocytes in sections (left panel), as well as cultured central (middle panel) and peripheral (right panel) keratocytes, were labeled with an antibody targeting choline acetyltransferase (ChAT; TRITC; red), and double stained with DAPI to visualize the nuclei (blue). Both the keratocytes in tissue sections and the cultured keratocytes expressed ChAT. **(C)** Keratocytes in sections (left panel), as well as cultured central (middle panel) and peripheral (right panel) keratocytes, were labeled with muscarinic acetylcholine receptors (mAChR M~1~, mAChR M~2~, mAChR M~3~, mAChR M~4~, and mAChR~5~; TRITC; red) and double stained with DAPI (blue). mAChR M~1~ was present in cultured cells but not in tissue sections, mAChR M~2~ was absent in both cultured cells and tissue sections. Remaining receptors (mAChR M~3~, mAChR M~4~, and mAChR M~5~) were expressed in both tissue sections and cultured cells. **(D)** 250,000 central or peripheral keratocytes grown in either 2% FBS or 0% FBS were lysed and expression of muscarinic acetylcholine receptors (mAChR M~1~ \[52 kDa\], mAChR M~3~ \[75 kDa\], mAChR M~4~ \[74 kDa\], and mAChR~5~ \[60 kDa\]~;~ mAChR M~2~ was not expressed) was analyzed by western blot. mAChR M~1~ expression was significantly higher in central keratocytes grown in 0% FBS than in central keratocytes grown in 2% FBS (\*\*\*p\<0.001), significantly higher in peripheral keratocytes grown in 2% FBS than in central keratocytes grown in same the condition (\*p\<0.05), and significantly higher in central keratocytes grown in 0% FBS than in peripheral keratocytes grown in the same condition (\*\*\*p\<0.001). mAChR M~3~ expression was significantly higher in central keratocytes grown in 2% FBS than in both central keratocytes grown in 0% FBS (\*\*\*p\<0.001) and peripheral keratocytes grown in 2% FBS (\*\*\*p\<0.001). Central keratocytes grown in 0% FBS expressed significantly more mAChR M~3~ than peripheral keratocytes grown in same conditions (\*\*\*p\<0.001) and peripheral keratocytes grown in 2% FBS expressed more mAChR M~3~ than peripheral cells grown in 0% FBS (\*\*p\<0.01). Expression of mAChR M~4~ was significantly higher in central keratocytes grown in 2% FBS than in peripheral keratocytes grown in same conditions (\*\*p\<0.01). Expression of mAChR~5~ was significantly higher in peripheral keratocytes grown in 2% FBS than in both central keratocytes grown in same conditions (\*\*\*p\<0.001) and peripheral keratocytes grown in 0% FBS (\*\*\*p\<0.001). mAChR~5~ expression was also significantly higher in central keratocytes grown in 0% FBS than in peripheral keratocytes grown in same conditions (\*\*p\<0.01). β-actin (42 kDa) served as a loading control. Values are means ± SD.](pone.0134157.g004){#pone.0134157.g004}

Human keratocytes produce glutamate and express glutamate receptor NMDAR1 {#sec019}
-------------------------------------------------------------------------

Presence and differences in amount of glutamate was measured by glutamate assay. Two culture conditions were tested. Central and peripheral keratocytes were cultured in either DMEM/F12 medium supplemented with 2% FBS or 0% FBS. Central keratocytes grown in these two conditions, as well as peripheral keratocytes grown in these two conditions, were compared. Moreover, comparison was made between central and peripheral keratocytes. Levels of glutamate were significantly higher in central and peripheral keratocytes culture supernatants collected from cells grown in 0% FBS than in supernatants collected from cells grown in 2% FBS. Levels of glutamate in cell lysates were significantly higher in peripheral keratocytes grown in 2% FBS than in peripheral keratocytes grown in 0% FBS ([Fig 5A](#pone.0134157.g005){ref-type="fig"}). Expression of glutamate and its receptor NMDAR1 was also analyzed by immunohistochemistry and immunocytochemistry. Glutamate was expressed in both keratocytes in tissue sections and in cultured cells ([Fig 5B](#pone.0134157.g005){ref-type="fig"}). Glutamate receptor NMDAR1 was expressed in keratocytes in tissue sections and in cultured cells ([Fig 5C](#pone.0134157.g005){ref-type="fig"}). To quantify and compare NMDAR1 expression under different culturing conditions and two types of keratocytes, western blot and densitometry analyses were performed. NMDAR1 expression was significantly higher in both central and peripheral keratocytes grown in 2% FBS than in central and peripheral keratocytes grown in 0% FBS. Expression of NMDAR1 was also significantly higher in central keratocytes grown in 0% FBS than in peripheral keratocytes grown in the same condition.

![Glutamate and NMDAR1 expression in keratocytes.\
**(A)** Glutamate assay of cultured central and peripheral keratocytes. 250,000 cells were grown for 24h in 6 well plates in DMEM/F12 supplemented with either 2% or 0% FBS. Supernatant was collected, cell were lysed and subjected to the glutamate assay. Levels of glutamate were significantly higher in central and peripheral keratocyte culture supernatants collected from cells grown in 0% FBS than in supernatants collected from cells grown in 2% (\*\*\*p\<0.001 for central and \*\*\*p\<0.001 for peripheral keratocytes). Levels of glutamate in cell lysates were significantly higher in peripheral keratocytes grown in 2% FBS than in peripheral keratocytes grown in 0% FBS (\*p\<0.05) **(B)** Keratocytes in sections (left panel), as well as cultured central (middle panel) and peripheral (right panel) keratocytes, were labeled with glutamate antibody (TRITC; red) and double stained with DAPI to visualize the nuclei (blue). Glutamate was expressed in both keratocytes in tissue sections and in cultured keratocytes. **(C)** Cornea sections (left panel), as well as cultured central (middle panel) and peripheral (right panel) keratocytes were labeled with glutamate receptor NMDAR1 (TRITC; red) and double stained with DAPI. NMDAR1 was expressed in keratocytes in tissue sections and in cultured keratocytes. **(D)** 250,000 central or peripheral keratocytes grown in either 2% FBS or 0% FBS were lysed and expression of NMDAR1 (105 kDa) was analyzed by western blot. NMDAR1 expression was significantly higher in both central and peripheral keratocytes grown in 2% FBS than in central and peripheral keratocytes grown in 0% FBS (\*p\<0.05 for central keratocytes, \*p\<0.05 for peripheral keratocytes). Expression of NMDAR1 was also significantly higher in central keratocytes grown in 0% FBS than in peripheral keratocytes grown in same conditions (\*\*p\<0.01). β-actin (42 kDa) served as a loading control. Values are means ± SD.](pone.0134157.g005){#pone.0134157.g005}

Discussion {#sec020}
==========

The present study shows that human keratocytes express an array of neuropeptides and neurotransmitters that traditionally have been seen as neuron specific. It also shows that keratocytes express receptors for these substances, making them susceptible to stimulation by neuropeptides/neurotransmitters in an autocrine and/or paracrine manner, in the latter case possibly through secretion of substances from corneal nerves. The possible importance of this expression profile of neuropeptides and neurotransmitters in human corneal stromal cells is here discussed in the context of the known functional properties of these substances and their relevance for processes included in corneal wound healing.

Methodological aspects: Phenotype of human keratocytes in primary cultures in vitro {#sec021}
-----------------------------------------------------------------------------------

In the absence of injury or pathology, keratocytes of the corneal stroma are considered as quiescent cells, with a low rate of proliferation and apoptosis \[[@pone.0134157.ref001]\]. However the culture conditions (including the factors added to the medium), the concentration of cells, and the stiffness of the support can influence the cell phenotype *in vitro* \[[@pone.0134157.ref034], [@pone.0134157.ref035]\]. For example, it has been shown that FBS can induce a fibroblastic phenotype on keratocytes \[[@pone.0134157.ref036]\]. To determine whether the culture conditions of the present study (2% FBS or 0% FBS) modified the cells' phenotype and/or function, expression of several keratocyte markers was analyzed and compared between different culturing conditions. Keratocytes isolated from the stroma and cultured in serum free medium should retain their phenotype and maintain the expression of specific markers such as aldehyde dehydrogenase (ALDH) and keratocan. Keratocan, a cornea-specific keratan sulfate proteoglycan \[[@pone.0134157.ref031]\] was abundantly expressed in cultured cells regardless of the culturing condition (2% and 0% FBS). However, ALDH, a corneal crystalline which helps to maintain the cellular transparency was expressed in low amounts and surprisingly cells cultured in serum free medium expressed lower amounts of this marker. Lumican is a 38 kDa protein belonging to the small leucine-rich proteoglycans and is expressed in the extracellular matrix (ECM) of various tissues including the corneal stroma \[[@pone.0134157.ref037]\] in which it is produced by keratocytes. It has been well described that during activation of keratocytes to myofibroblasts the cells decrease the expression of keratan sulfate proteoglycans and increase the expression of α-SMA, a marker of myofibroblasts \[[@pone.0134157.ref038]\]. Under our culture conditions, cultured cells expressed high amounts of lumican, with non-significant differences between cells cultured in 2% and 0% FBS. CD34 is a well-established marker of quiescent keratocytes *in vivo*. Its role in keratocytes has not yet been elucidated but there is evidence that it might play a role in regulation of differentiation, adhesion, and quiescence. Under our culture conditions, cultured cells expressed high amounts of this protein. Cells cultured in serum free medium had lower expression of CD34 than cells cultured in 2% serum medium. Taken together, the cultured human corneal stroma cells of this study express the most important keratocyte markers and are thus deemed to be of a preserved keratocyte phenotype. Serum is able to alternate the cell phenotype, although to a minor degree in the amount of 2% FBS.

As the human cornea can be divided into a central and a limbal part (with partly different clinical features), we derived keratocytes from both parts separately to investigate if these two differ in expression patterns of neuropeptides/neurotransmitters. However, as precise separation of these two parts *in vitro* is impossible, we used a term 'peripheral' for keratocytes derived from the limbus region and adjacent corneal tissue. Both central and peripheral keratocytes expressed keratocan, which is a cornea-specific marker \[[@pone.0134157.ref007]\] that has been shown to be expressed in cultured keratocytes \[[@pone.0134157.ref006], [@pone.0134157.ref008]--[@pone.0134157.ref010]\].

Neuropeptides and their receptors in keratocytes {#sec022}
------------------------------------------------

The results of the present study show that both central and peripheral keratocytes in culture express the two tachykinins of interest, SP and NKA, as well as their preferred receptors NK-1R and NK-2R, respectively. SP and NKA belong to a family of neuropeptides which have a variety of pharmacological actions both in the central nervous system and in the periphery \[[@pone.0134157.ref028]\]. SP and its preferred receptor have been found to be expressed in tumor cells \[[@pone.0134157.ref039]\], tenocytes \[[@pone.0134157.ref029]\] and colonic epithelial cells \[[@pone.0134157.ref040]\], and also previously in cultured keratocytes from human cornea \[[@pone.0134157.ref018]\]. NKA expression has been discovered, for example, in monocytes and lymphocytes \[[@pone.0134157.ref041], [@pone.0134157.ref042]\]. These two substances have been linked to proliferative and apoptotic properties \[[@pone.0134157.ref043], [@pone.0134157.ref044]\], as well as being known to interact with components of extracellular matrix, mediating migration and playing a role in inflammatory responses \[[@pone.0134157.ref045]\]. As these mechanisms play a role in stromal wound healing, it might be speculated that both SP and NKA have effects in corneal wound healing processes. The fact that keratocytes also expressed the SP and NKA receptors, suggests that keratocytes themselves indeed could be subjected to SP and NKA actions.

Catecholamines and their receptors in keratocytes {#sec023}
-------------------------------------------------

Presence of catecholamines (adrenaline, noradrenaline, and dopamine) was confirmed in both central and peripheral keratocytes in culture. It has been shown that catecholamines are synthesized both in the brain and in non-neuronal organs and cells such as adrenal medulla, gut cells, platelets, and lymphocytes \[[@pone.0134157.ref046]--[@pone.0134157.ref049]\]. However, when we analyzed expression of TH--an enzyme responsible for catalyzing the conversion of the amino acid L-tyrosine to L-DOPA--we found that cultured cells express it but the keratocytes in tissue sections do not. Moreover, when we analyzed the expression of adrenaline and noradrenaline adrenoreceptors (α1 adrenergic receptor \[ADRA1\] and β2 adrenergic receptor \[ADRB2\]) we found that they are not expressed in keratocytes in tissue sections, and that their expression in the cultured cells was inconclusive as their expression varied among cells obtained from different donors. As catecholamines play a role in stress response \[[@pone.0134157.ref050]\] it might be that the cultured cells are in stress conditions and that this explains why they sometimes express the adrenaline and noradrenaline receptors. Also, catecholamines have been found to regulate angiogenesis in tumors \[[@pone.0134157.ref051]\]. Taken together, the expression of catecholamines and the presence of adrenoreceptors in cultured cells but not in keratocytes in tissue sections suggest that they might play a role in corneal stress response, which might be due to injury.

ACh and muscarinic receptors in keratocytes {#sec024}
-------------------------------------------

ACh, a classical neurotransmitter, is thought to be synthesized by all living cells \[[@pone.0134157.ref030]\]. In the present study it was found that ACh is synthesized by both central and peripheral cultured keratocytes, and that these cells also express muscarinic ACh receptors (subtypes M~1~, M~3~, M~4~, and M~5~). Previous studies have shown that corneal epithelium contains high concentrations of ACh and its enzymes \[[@pone.0134157.ref019]--[@pone.0134157.ref021]\]. Furthermore, studies on mAChRs in corneal epithelium and endothelium have shown that mAChR M~2~, mAChR M~4~, and mAChR M~5~ are expressed by these cells, but that mAChR M~1~ and mAChR M~3~ are not \[[@pone.0134157.ref052]\]. It would be interesting to study why there are differences in the receptor patterns within the cornea and if there are any physiological reasons for that. ACh is known to induce proliferation in human tenocytes \[[@pone.0134157.ref053]\], and keratocytes \[[@pone.0134157.ref054]\] have an anti-apoptotic effect and facilitate wound healing in epithelial cell \[[@pone.0134157.ref055]\], as well as induce angiogenesis \[[@pone.0134157.ref056]\], all of which are effects that are of importance also in corneal wound healing.

Glutamate and NMDA1R in keratocytes {#sec025}
-----------------------------------

Glutamate, an important neurotransmitter, and its receptors have been found in peripheral non-excitable cells in tissues such as taste buds, intestine, spleen, skin, and bone, as well as in platelets and lymphocytes \[[@pone.0134157.ref057]--[@pone.0134157.ref060]\]. In the present study, we found that cultured keratocytes express and secrete glutamate. Glutamate receptor NMDAR1 was also expressed by the keratocytes in culture. It has been found that glutamate is linked to modulation of tumor cell proliferation and migration \[[@pone.0134157.ref061]\], which might imply that it could play a similar role on cells in corneal would healing processes.

Differences in expression profiles between peripheral and central keratocytes {#sec026}
-----------------------------------------------------------------------------

Limbal epithelial stem cells are located at the basal epithelium of the palisades of Vogt, and regulated by their unique niche components \[[@pone.0134157.ref062]\]. Compared to the central keratocytes, the limbal keratocytes have a close spatial relationship with the limbal epithelial stem cells, suggesting the possibility of cytokine cross-talk between the two cell types. It has been reported that cells of limbal stromal origin contribute to the proliferation of limbal epithelial stem cells through paracrine signaling \[[@pone.0134157.ref063], [@pone.0134157.ref064]\]. Although limited reports describe the interactions between the limbal stem cells and other limbal niche components, the nerves may be involved in the regulation of limbal niche, since a previous study has confirmed that the limbal stroma is heavily innervated \[[@pone.0134157.ref065]\]. In the present study, we found that there were significant differences in the expression profiles of the neuropeptides/neurotransmitters and their receptors between peripheral and central corneal stromal cells, which might suggest possible differences in their contributions to the maintenance of limbal epithelial stem cells, a phenomenon previously shown \[[@pone.0134157.ref066]\].

Concluding remarks {#sec027}
------------------

In conclusion, keratocytes in tissue sections and cultured human keratocytes express a broad range of neurotransmitters and neuropeptides as well as their receptors. The expression profiles seem to be changed upon culturing of the cells and show differences between peripheral and central keratocytes. The results, together with known effects of the neuropeptides/neurotransmitters in other tissues, suggest that neuronal and non-neuronal neuropeptides/neurotransmitters may play a role in corneal wound healing, which warrants further functional studies on their effect in different model systems of the cornea.

Supporting Information {#sec028}
======================

###### Gene expression analysis of neuropeptides and neurotransmitters.

250,000 cells were grown for 24h in 6 well plates. Cells were lysed and total mRNA was extracted. Gene expression was assessed by RT qPCR. Cultured central and peripheral keratocytes expressed substance P and neurokinin A gene (TAC1), genes involved in catecholamine synthesis (DDC), genes involved in glutamate synthesis (GLS, GOT), and receptor genes: TACR1 (for the substance P receptor NK-1R), TACR2 (for the neurokinin A receptor NK-2R), CHRM1-5 (muscarinic acetylcholine receptors M1-M5), DRD2 (dopamine receptor), ADRA1B and ADRB2 (adrenergic adrenaline and noradrenaline receptors).

(TIF)

###### 

Click here for additional data file.
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